×
About 59,138 results

ALLMedicine™ Hepatitis C Virus Center

Research & Reviews  28,387 results

Sociodemographic characteristics associated with hepatitis C among patients admitted fo...
https://doi.org/10.1080/10550887.2021.1935187
Journal of Addictive Diseases; Alexander R, Agboola O et. al.

Jun 14th, 2021 - While Opioid use disorder (OUD)-related mortality is epidemic in the United States, regions like Appalachia are disproportionately affected. Moreover, a dual epidemic of Hepatitis C virus (HCV) infections and OUD-related admissions has been observ...

Universal Screening for Hepatitis C Virus in the ED Using a Best Practice Advisory.
https://doi.org/10.5811/westjem.2021.1.49667
The Western Journal of Emergency Medicine; Ford JS, Chechi T et. al.

Jun 14th, 2021 - In 2019 the United States Preventive Services Task Force (USPSTF) released draft guidelines recommending universal hepatitis C virus (HCV) screening for individuals aged 18-79. We aimed to assess the efficacy of an emergency department-based HCV s...

Utilizing patient perception of group treatment in exploring medication adherence, soci...
https://doi.org/10.1016/j.jsat.2021.108459
Journal of Substance Abuse Treatment; Howard KA, Rennert L et. al.

Jun 12th, 2021 - People who inject drugs (PWID) have a high prevalence of hepatitis C virus (HCV). Group treatment is a practical option for addressing barriers to treatment in this population. Prior research on group treatment has resulted in mixed conclusions ab...

Medicaid Expansion Association with End-Stage Liver Disease Mortality Depends on Lenien...
https://doi.org/10.1002/lt.26209
Liver Transplantation : Official Publication of the Ameri... Wahid N, Lee J et. al.

Jun 12th, 2021 - The Affordable Care Act (ACA) expanded Medicaid around the same time that direct-acting antivirals (DAAs) became widely available for the treatment of hepatitis C virus (HCV). However, there is significant variation in Medicaid HCV treatment eligi...

Using vibration controlled transient elastography and FIB-4 to assess liver cirrhosis i...
https://doi.org/10.1097/MD.0000000000026200
Medicine Saleem N, Miller LS et. al.

Jun 11th, 2021 - We assessed the performance characteristics of the Fibrosis-4 (FIB-4) score in a veteran population with chronic hepatitis C virus (HCV) infection and used vibration controlled transient elastography (VCTE) as the gold standard.All VCTE studies we...

see more →

Guidelines  51 results

EASL recommendations on treatment of hepatitis C: Final update of the series☆.
https://doi.org/10.1016/j.jhep.2020.08.018
Journal of Hepatology; , et. al.

Sep 21st, 2020 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an...

Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Serv...
https://doi.org/10.1001/jama.2020.1123
JAMA , Owens DK et. al.

Mar 2nd, 2020 - Hepatitis C virus (HCV) is the most common chronic blood-borne pathogen in the US and a leading cause of complications from chronic liver disease. HCV is associated with more deaths than the top 60 other reportable infectious diseases combined, in...

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline
https://annals.org/aim/fullarticle/2751913/prevention-diagnosis-evaluation-treatment-hepatitis-c-virus-infection-chronic-kidney

Sep 23rd, 2019 - Description: The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD) is an extensive updat...

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chro...
https://doi.org/10.7326/M19-1539
Annals of Internal Medicine; Gordon CE, Berenguer MC et. al.

Sep 23rd, 2019 - This article has been corrected. The original version (PDF) is appended to this article as a Supplement. The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatmen...

FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier, and Vosevi in some patients with advanced liver disease
https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-rare-occurrence-serious-liver-injury-use-hepatitis-c-medicines-mavyret-zepatier-and

Aug 27th, 2019 - The Food and Drug Administration (FDA) has received reports that the use of Mavyret, Zepatier, or Vosevi to treat chronic hepatitis C in patients with moderate to severe liver impairment has resulted in rare cases of worsening liver function or li...

see more →

Drugs  33 results see all →

Clinicaltrials.gov  29,357 results

Sociodemographic characteristics associated with hepatitis C among patients admitted fo...
https://doi.org/10.1080/10550887.2021.1935187
Journal of Addictive Diseases; Alexander R, Agboola O et. al.

Jun 14th, 2021 - While Opioid use disorder (OUD)-related mortality is epidemic in the United States, regions like Appalachia are disproportionately affected. Moreover, a dual epidemic of Hepatitis C virus (HCV) infections and OUD-related admissions has been observ...

Universal Screening for Hepatitis C Virus in the ED Using a Best Practice Advisory.
https://doi.org/10.5811/westjem.2021.1.49667
The Western Journal of Emergency Medicine; Ford JS, Chechi T et. al.

Jun 14th, 2021 - In 2019 the United States Preventive Services Task Force (USPSTF) released draft guidelines recommending universal hepatitis C virus (HCV) screening for individuals aged 18-79. We aimed to assess the efficacy of an emergency department-based HCV s...

Utilizing patient perception of group treatment in exploring medication adherence, soci...
https://doi.org/10.1016/j.jsat.2021.108459
Journal of Substance Abuse Treatment; Howard KA, Rennert L et. al.

Jun 12th, 2021 - People who inject drugs (PWID) have a high prevalence of hepatitis C virus (HCV). Group treatment is a practical option for addressing barriers to treatment in this population. Prior research on group treatment has resulted in mixed conclusions ab...

Medicaid Expansion Association with End-Stage Liver Disease Mortality Depends on Lenien...
https://doi.org/10.1002/lt.26209
Liver Transplantation : Official Publication of the Ameri... Wahid N, Lee J et. al.

Jun 12th, 2021 - The Affordable Care Act (ACA) expanded Medicaid around the same time that direct-acting antivirals (DAAs) became widely available for the treatment of hepatitis C virus (HCV). However, there is significant variation in Medicaid HCV treatment eligi...

Using vibration controlled transient elastography and FIB-4 to assess liver cirrhosis i...
https://doi.org/10.1097/MD.0000000000026200
Medicine Saleem N, Miller LS et. al.

Jun 11th, 2021 - We assessed the performance characteristics of the Fibrosis-4 (FIB-4) score in a veteran population with chronic hepatitis C virus (HCV) infection and used vibration controlled transient elastography (VCTE) as the gold standard.All VCTE studies we...

see more →

News  1,307 results

Fast Five Quiz: Are You Prepared to Confront Hepatitis C?
https://reference.medscape.com/viewarticle/833773

Jun 3rd, 2021 - Hepatitis C is a liver disease caused by the hepatitis C virus (HCV). It is a major public health problem. Infection with HCV can lead to both acute and chronic hepatitis, varying in severity from a mild illness of short duration to a serious, lif...

Liver Transplant Outcomes Improving for US Patients With HIV/HCV
https://www.medscape.com/viewarticle/952065

May 27th, 2021 - While liver transplant outcomes were historically poor in people coinfected with HIV and hepatitis C virus (HCV), they have improved significantly in the era of direct-acting antiviral (DAA) therapy, a recent analysis of U.S. organ transplant data...

Drops in Hepatitis C Testing, Treatment Spark Concern
https://www.medscape.com/viewarticle/951421

May 18th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The COVID-19 pandemic has coincided with sharp declines in routine testing for and treatment of hepatitis C virus (HCV) infection, according to th...

Hepatitis C Drugs Work Synergistically With Remdesivir
https://www.medscape.com/viewarticle/950322

May 2nd, 2021 - (Reuters) - Combining Gilead Sciences' antiviral drug remdesivir - the current standard of care for hospitalized COVID-19 patients - with oral drugs used to treat hepatitis C virus (HCV) might be more effective than remdesivir alone, laboratory ex...

Ravidasvir-Sofosbuvir Combo Shows Promise in Chronic Hep C Infection
https://www.medscape.com/viewarticle/950088

Apr 28th, 2021 - NEW YORK (Reuters Health) - A combination of ravidasvir and sofosbuvir appears to be an effective treatment for chronic hepatitis C virus (HCV) infection across a diverse pool of patients who took part in the first half of the single-arm STORM-C-1...

see more →

Patient Education  3 results see all →